Viewing Study NCT06531395


Ignite Creation Date: 2025-12-24 @ 1:19 PM
Ignite Modification Date: 2026-01-25 @ 1:20 AM
Study NCT ID: NCT06531395
Status: TERMINATED
Last Update Posted: 2025-05-21
First Post: 2024-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease
Sponsor: Kiniksa Pharmaceuticals International, plc
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: KPL-404-C221
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View